NNC4005-0001

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NNC4005-0001, covering 2026-02-11 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat [Phase 1]

See pricing